NASDAQ
Acrivon Therapeutics, Inc. Common Stock (ACRV) has a fcf yield of -70.40% as of Friday, May 29, 2026. This represents a 214.52% decrease compared to its 12-month average of -22.38%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.